Melasma treatment

Melasma treatment is a dermatological intervention that targets hyperpigmentation on facial skin. Insurance plans, such as those from UnitedHealthcare and Aetna, typically classify melasma treatments like chemical peels, hydroquinone creams, and laser therapy as cosmetic procedures.

Medicare does not cover melasma treatments unless a physician documents underlying medical necessity. Out-of-pocket costs for topical prescription creams range from $30 to $200 monthly, depending on ingredients like tretinoin or hydroquinone.

Dermatologists frequently recommend combination therapies–including tranexamic acid or azelaic acid–for patients who show resistance to monotherapy. Chemical peels like glycolic acid, which may cost $150 to $300 per session, are rarely reimbursed by insurance carriers such as Cigna or Anthem, per the Insurance Information Database.

Some employee health benefit plans reimburse partial costs only if melasma results from hormone therapy or medication side effects, requiring prior authorization and provider documentation. Medical necessity appeals occur in fewer than 5% of cases reviewed by Blue Cross Blue Shield affiliates.

FDA-approved prescription agents for melasma include hydroquinone 4% and triple-combination creams containing fluocinolone, tretinoin, and hydroquinone. Cosmetic treatments–such as fractional lasers–averaged $450 per session in U.S.

Cities like Los Angeles or Miami in 2023, with insurance consistently denying coverage based on elective status. Insurers recognize documented adverse drug reactions resulting in melasma but apply strict criteria for approving any covered intervention.